tirzepatide court ruling Readout Newsletter: Makary hearing, Hims, Nimbus, Ozempic court decision on tirzepatide Judge

It is predicted that adverse drug reactions cost the NHS more than 2.2bn a year in hospital stays alone. A spokesperson for Lilly, the maker of Mounjaro, said: Patient safety is Lillys top priority

King paid Palatin $20M upfront

This takes about 15 to 20 minutes

H ASCO GU 2026 ASCO GU 2026 (American Society of Clinical Oncology Genitourinary Cancers Symposium) is one of the leading international events dedicated to genitourinary cancers, bringing together specialists from around the world to discuss the latest advances in diagnosis, treatment, and clinical research

Learn about our tip-free policy Still have questions

The United States now has its first generic GLP-1 for weight loss, but rollout in Europe and other regions will depend on local patents and regulatory checks